JVM: 1-(4-{5-[(piperidin-4-yl)methoxy]-3-[4-(1H-pyrazol-4-yl)phenyl]pyrazin-2-yl}phenyl)methanamine
JVM is a Ligand Of Interest in 6MO2 designated by the RCSB
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6MO2_JVM_B_1201 | 4% | 2% | 0.193 | 0.566 | 3.82 | 3.04 | 23 | 21 | 4 | 0 | 100% | 1 |
| 6MO2_JVM_A_1201 | 3% | 3% | 0.195 | 0.553 | 3.3 | 2.51 | 21 | 23 | 7 | 0 | 100% | 1 |
